Multiple Assemblies exist for SMTL entry 4f08
Discovery and Optimization of C-2 Methyl Imidazo-pyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2; X-RAY DIFFRACTION 2.82 Å

	SMTL ID 4f08.1 Ligands 1-(piperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine Polypeptides Tyrosine-protein kinase JAK2 Oligo-state monomer
	SMTL ID 4f08.2 Ligands 1-(piperidin-4-yl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine Polypeptides Tyrosine-protein kinase JAK2 Oligo-state monomer